Ocular Therapeutix, Inc. (OCUL)

9.525 +0.57 (+6.37%) USD  |  NASDAQ  |  Feb 25, 15:50
More

Ocular Therapeutix EBITDA (5 Year Growth)

EBITDA (5 Year Growth) Chart

View EBITDA (5 Year Growth) for OCUL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (5 Year Growth) Range, Past 5 Years

View EBITDA (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (5 Year Growth) Benchmarks

View EBITDA (5 Year Growth) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Boston Scientific Corp. Upgrade
Alnylam Pharmaceuticals, Inc. --
EyePoint Plc --
Vertex Pharmaceuticals, Inc. Upgrade